SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: Frostman who wrote (22653)1/4/2000 9:21:00 AM
From: Bipin Prasad  Read Replies (1) | Respond to of 23519
 
from briefing.com;
VIVUS Inc (VVUS) 4 1/32: Company's VIVUS International subsidiary announces resolution of all financial obligations relating to the return to VIVUS of marketing and distribution rights for MUSE from AstraZeneca. VVUS expects resolution to result in significantly increased revenues for Q4 of 1999 and the Q1 of 2000.

InSook Prasad